| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/01/2009 | EP2075252A1 Nk1 receptor antagonist composition |
| 07/01/2009 | EP2075001A1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 07/01/2009 | EP2074997A1 Use of Asimadoline for the treatment of digestive disorders |
| 07/01/2009 | EP2074149A2 Compositions and methods relating to glucagon receptor antibodies |
| 07/01/2009 | EP2074119A1 Indole compound |
| 07/01/2009 | EP2074117A2 Heteromonocyclic compound and use thereof |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2073834A2 Methods for administering long-lasting hypoglycemic agents |
| 07/01/2009 | EP2073817A1 Medicagenic acid saponin and uses thereof |
| 07/01/2009 | EP2073810A2 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile compound for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 07/01/2009 | EP2073806A2 Use of spiro-oxindole compounds as therapeutic agents |
| 07/01/2009 | EP2073805A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/01/2009 | EP2005964A9 The medicament for treating hyperphospheremia and preparation thereof |
| 07/01/2009 | EP1868999B1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 07/01/2009 | EP1838710B1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/01/2009 | EP1831252B1 Glp-1 analog fusion protein formulations |
| 07/01/2009 | EP1740583B1 Oxadiazolone derivatives as ppar delta agonists |
| 07/01/2009 | EP1694354B1 Method for preventing and treating diabetes using neurturin |
| 07/01/2009 | EP1666048A4 Method for producing insulin from a natural source and insulin |
| 07/01/2009 | EP1611104B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 07/01/2009 | EP1599455B1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506835C Segment of alginic acid oligosaccharide, preparation method and application |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506807C Amide derivatives as GK activators |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506794C New method for preparing medicine mitiglinide for treating diabetes |
| 07/01/2009 | CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506769C Preparation and use of compounds i.e., 1,3-dihydroxy-5-alkyl benzene as inhibitor of protein-tyrosine-phosphatase 1B |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 07/01/2009 | CN100506220C Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553845 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 06/30/2009 | US7553642 Capable of sodium-independently transporting branched amino acids |
| 06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
| 06/30/2009 | CA2621950A1 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 06/30/2009 | CA2391625C Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan |
| 06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2143486C Method of improving the immune response |
| 06/25/2009 | WO2009079601A1 Methods and systems for sublingual guarana administration |
| 06/25/2009 | WO2009078746A1 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof |
| 06/25/2009 | WO2009078498A1 Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
| 06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 06/25/2009 | WO2009078348A1 Method of producing liquid earthworm extract and method of producing dry earthworm powder |
| 06/25/2009 | WO2009077585A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/25/2009 | WO2009076742A1 Effervescent dietary composition for enhancing delivery of dietary ingredients |
| 06/25/2009 | WO2009076693A1 Octahydroquinoli zines for antidiabetic treatment |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 06/25/2009 | WO2009040730A3 Pyrrolidines and piperidines as orexin receptor antagonists |
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009007856A3 Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium |
| 06/25/2009 | WO2008131149A3 Crystal forms of saxagliptin and processes for preparing same |
| 06/25/2009 | WO2008098396A3 Oxazolidinones and their use as hypocholesterolemic agents |
| 06/25/2009 | WO2008068173A9 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| 06/25/2009 | WO2008067257A8 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163586 Bis-(Sulfonylamino) Derivatives in Therapy 205 |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163547 Indene derivatives, their preparation and use as medicaments |
| 06/25/2009 | US20090163546 Diacylglycerol acyltransferase inhibitors |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163520 MNK1 or MNK2 Inhibitors |
| 06/25/2009 | US20090163517 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163511 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 06/25/2009 | US20090163500 Compositions and methods for treating lysosomal disorders |
| 06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163481 Ppar-delta ligands and methods of their use |
| 06/25/2009 | US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
| 06/25/2009 | US20090163469 Organic Compounds |
| 06/25/2009 | US20090163463 Organic Compounds |
| 06/25/2009 | US20090163443 from the culture of Streptomyces vayuensis strain; Nonadeca-6-enoic acid-3-(hexadecyloxy-hydroxy-thiophosphoryloxy)-quinoxalin-2-yl ester, useful particularly for prevention of obesity and treatment of diabetes, sleep apnea, nervous system, cardiovascular and gastrointestinal disorders |
| 06/25/2009 | US20090162442 Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin |
| 06/25/2009 | US20090162345 Materials and Methods for Reversing Type-1 Diabetes |
| 06/25/2009 | US20090162325 Cell implantation to prevent and/or treat autoimmune disease |
| 06/25/2009 | US20090162286 Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions |
| 06/25/2009 | DE102007063671A1 Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New crystalline Diphenylazetidinonhydrate, pharmaceutical compositions containing them and their use |
| 06/25/2009 | DE102007061764A1 Anellierte Cyanopyridine und ihre Verwendung Fused cyanopyridines and their use |
| 06/25/2009 | DE102007061763A1 Substituierte azabicyclische Verbindungen und ihre Verwendung Substituted azabicyclic compounds and their use |